Nitti V1, Drake M2, Everaert K3, Rovner E4, Dmochowski R5, Ginsberg D6, Radomski S7, Aboushwareb T8, Chang C9, Chapple C10
1. New York University Langone Medical Center, New York, NY, USA, 2. Bristol Urological Institute, Bristol, UK, 3. Ghent University Hospital, Ghent, Belgium, 4. Medical University of South Carolina, Charleston, SC, USA, 5. Vanderbilt University Medical Center, Nashville, TN, USA, 6. USC Institute of Urology, Los Angeles, CA, USA, 7. University of Toronto, Toronto, Canada, 8. Allergan plc, Irvine, CA, USA, 9. Allergan plc, Bridgewater, NJ, USA, 10. The Royal Hallamshire Hospital, Sheffield Teaching Hospitals, NHS Foundation Trust, Sheffield, UK
Overactive Bladder, Clinical Trial, Incontinence, Detrusor Overactivity, Quality of Life (QoL)